Repurposing old weapons for new battles Sponsor In the news Repurposing old weapons for new battles Luke Hoeppner Jan 02, 2018
Luke Hoeppner Feb 07, 2018 Promising work, especially in light of FDA-approved AAV gene therapy entering the U.S. market early this year to restore vision in patients diagnosed with biallelic RPE65-mutation-associated ret...
Recent Comments
Promising work, especially in light of FDA-approved AAV gene therapy entering the U.S. market early this year to restore vision in patients diagnosed with biallelic RPE65-mutation-associated ret...